CN100537556C - 单糖的端基异构衍生物 - Google Patents
单糖的端基异构衍生物 Download PDFInfo
- Publication number
- CN100537556C CN100537556C CNB038073757A CN03807375A CN100537556C CN 100537556 C CN100537556 C CN 100537556C CN B038073757 A CNB038073757 A CN B038073757A CN 03807375 A CN03807375 A CN 03807375A CN 100537556 C CN100537556 C CN 100537556C
- Authority
- CN
- China
- Prior art keywords
- hydrogen
- compound
- group
- alkyl
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPS1434A AUPS143402A0 (en) | 2002-03-28 | 2002-03-28 | Anomeric derivatives of monosaccharides |
| AUPS1434 | 2002-03-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1642932A CN1642932A (zh) | 2005-07-20 |
| CN100537556C true CN100537556C (zh) | 2009-09-09 |
Family
ID=3835023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB038073757A Expired - Lifetime CN100537556C (zh) | 2002-03-28 | 2003-03-28 | 单糖的端基异构衍生物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7737287B2 (enExample) |
| EP (1) | EP1487812A4 (enExample) |
| JP (1) | JP4610197B2 (enExample) |
| CN (1) | CN100537556C (enExample) |
| AU (1) | AUPS143402A0 (enExample) |
| CA (1) | CA2480578C (enExample) |
| DE (1) | DE03745223T1 (enExample) |
| WO (1) | WO2003082846A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7138531B2 (en) | 2001-10-15 | 2006-11-21 | Kemin Pharma B.V.B.A. | Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity |
| AU2002950657A0 (en) | 2002-08-08 | 2002-09-12 | Alchemia Limited | Derivatives of monosaccharides for drug discovery |
| AU2002951995A0 (en) | 2002-10-11 | 2002-10-31 | Alchemia Limited | Classes of compounds that interact with gpcrs |
| US7125854B2 (en) | 2003-01-07 | 2006-10-24 | Kemin Pharma B.V.B.A. | Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites |
| JP4707397B2 (ja) | 2003-01-07 | 2011-06-22 | ケミン・ファーマ・ヨーロッパ・ビー・ブイ・ビー・エイ | C型肝炎及びウシウイルス性下痢のウイルスのようなフラビウイルス科に分類される種によって引き起こされる感染の治療に有用な二環式炭水化物化合物 |
| US7368475B2 (en) | 2003-03-12 | 2008-05-06 | Kemin Pharma Bvba | Furanose-type bicyclic carbohydrates with biological activity |
| US7098243B2 (en) | 2003-09-16 | 2006-08-29 | Kemin Pharma Europe B.V.B.A. | Bicyclic carbohydrates as antiviral bioactives for the treatment of infections caused by the alphaherpesvirinae HSV-1 and HSV-2 |
| AU2006209794B2 (en) * | 2005-02-04 | 2010-07-08 | Alchemia Limited | Classes of compounds that interact with integrins |
| DE06704810T1 (de) * | 2005-02-04 | 2008-05-21 | Alchemia Ltd., Eight Mile Plains | Mit integrinen interagierende verbindungsklassen |
| PL1934388T3 (pl) * | 2005-10-04 | 2013-04-30 | Alchemia Ltd | Sposób projektowania leków |
| WO2007070947A1 (en) * | 2005-12-22 | 2007-06-28 | Alchemia Ltd | Antibacterial agents |
| WO2021155317A1 (en) | 2020-01-31 | 2021-08-05 | Avilar Therapeutics, Inc. | Asgpr-binding compounds for the degradation of extracellular proteins |
| KR20240017423A (ko) | 2021-05-03 | 2024-02-07 | 아빌라 테라퓨틱스, 인크. | 이뮤노글로불린 및 다른 단백질의 분해를 위한 강력한 asgpr-결합 화합물 |
| US12116382B2 (en) | 2022-11-28 | 2024-10-15 | Hongene Biotech Corporation | Functionalized N-acetylgalactosamine analogs |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008799A1 (en) * | 1996-08-26 | 1998-03-05 | Alchemia Pty. Ltd. | Oligosaccharide synthesis |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5331664A (en) * | 1976-09-02 | 1978-03-25 | Suami T | Production of novel nitroso urea derivatives |
| DE3347522A1 (de) * | 1983-12-30 | 1985-07-11 | Troponwerke GmbH & Co KG, 5000 Köln | N-glycosylierte carbonsaeureamid-derivate als mittel bei der bekaempfung von erkrankungen des rheumatischen formenkreises |
| DE3521994A1 (de) * | 1985-06-20 | 1987-01-02 | Bayer Ag | N-(2-aminoacylamido-2-desoxy-hexosyl)-amide-, -carbamate und -harnstoffe, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| HU208146B (en) * | 1989-11-14 | 1993-08-30 | Biogal Gyogyszergyar | Process for producing aminobenzoic acid-n-glycoside derivatives |
| US5449785A (en) * | 1991-07-24 | 1995-09-12 | Hoffmann-La Roche Inc. | Cyclohexane derivatives |
| JPH07242684A (ja) * | 1994-03-02 | 1995-09-19 | Japan Tobacco Inc | 新規なグルクロン酸化合物 |
| US5491152A (en) * | 1994-03-23 | 1996-02-13 | The Du Pont Merck Pharmaceutical Company | Derivatives of cyclic ethers and sulfides for the treatment of atherosclerosis |
| WO1997014709A1 (en) * | 1995-10-13 | 1997-04-24 | F. Hoffmann-La Roche Ag | Antisense oligomers |
| JP2002502393A (ja) * | 1997-05-29 | 2002-01-22 | インカラ・ファーマシューティカルズ・コーポレーション | 炭水化物骨格化合物及びライブラリー |
| US6197963B1 (en) * | 1998-08-13 | 2001-03-06 | The Trustees Of The University Of Pennsylvania | Non-peptide peptidomimetics |
| CA2415368A1 (en) * | 2000-07-13 | 2002-01-31 | Yi Jin | Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
| AUPR079700A0 (en) * | 2000-10-17 | 2000-11-09 | Alchemia Pty Ltd | Combinatorial libraries of monosaccharides |
| AUPR084400A0 (en) | 2000-10-18 | 2000-11-09 | Alchemia Pty Ltd | Immunoadjuvant systems |
-
2002
- 2002-03-28 AU AUPS1434A patent/AUPS143402A0/en not_active Abandoned
-
2003
- 2003-03-28 EP EP03745223A patent/EP1487812A4/en not_active Withdrawn
- 2003-03-28 CA CA2480578A patent/CA2480578C/en not_active Expired - Lifetime
- 2003-03-28 WO PCT/AU2003/000384 patent/WO2003082846A1/en not_active Ceased
- 2003-03-28 US US10/509,092 patent/US7737287B2/en active Active
- 2003-03-28 JP JP2003580313A patent/JP4610197B2/ja not_active Expired - Fee Related
- 2003-03-28 CN CNB038073757A patent/CN100537556C/zh not_active Expired - Lifetime
- 2003-03-28 DE DE03745223T patent/DE03745223T1/de active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008799A1 (en) * | 1996-08-26 | 1998-03-05 | Alchemia Pty. Ltd. | Oligosaccharide synthesis |
Non-Patent Citations (2)
| Title |
|---|
| 'Carbohydrate based mimetics in drug design: sugar aminoacids and carbohydrate scaffolds'. GRUNER S.A.W. ET AL.CHEM. REVIEWS,Vol.102 . 2002 * |
| 'Synthesis of oligomers of tetrahydrofuran amino acids:Furanose carbopeptides'. SMITH ET AL.CHEM. COMMUN.. 1998 * |
Also Published As
| Publication number | Publication date |
|---|---|
| US7737287B2 (en) | 2010-06-15 |
| JP2005526813A (ja) | 2005-09-08 |
| WO2003082846A1 (en) | 2003-10-09 |
| JP4610197B2 (ja) | 2011-01-12 |
| EP1487812A1 (en) | 2004-12-22 |
| CN1642932A (zh) | 2005-07-20 |
| EP1487812A4 (en) | 2006-07-26 |
| CA2480578C (en) | 2013-01-08 |
| DE03745223T1 (de) | 2007-05-03 |
| AUPS143402A0 (en) | 2002-05-09 |
| CA2480578A1 (en) | 2003-10-09 |
| US20050245746A1 (en) | 2005-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100537556C (zh) | 单糖的端基异构衍生物 | |
| WO2016064082A2 (ko) | 신규한 아미노알킬벤조티아제핀 유도체 및 이의 용도 | |
| WO2017217792A1 (ko) | 다이페닐메탄 유도체의 제조방법 | |
| WO2010056022A2 (en) | Melanocortin receptor agonists | |
| WO2013048177A2 (ko) | 셀레노펜-접합 방향족 화합물, 및 이의 제조 방법 | |
| WO2019078522A1 (ko) | 세레브론 단백질의 분해 유도 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물 | |
| AU2019310508A1 (en) | 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the same | |
| WO2018066872A1 (ko) | 3-페닐-2,3,4,8,9,10-헥사히드로피라노[2,3-f]크로멘 유도체 및 이의 광학 이성질체 합성 방법 | |
| WO2018226053A1 (ko) | 시클로프로필아민 유도체 화합물 및 이의 용도 | |
| WO2016190630A1 (en) | Heterocyclicalkyl derivative compounds as selective histone deacetylase inhibitors and pharmaceutical compositions comprising the same | |
| WO2018080127A1 (ko) | 아데노신 유도체를 포함하는 비알콜성 지방간염, 간섬유증 및 간경변증 예방 및 치료용 약학적 조성물 | |
| WO2014046441A1 (ko) | 돌라스타틴 10 유도체, 그의 제조방법 및 그를 포함하는 항암제 조성물 | |
| WO2010002115A2 (en) | Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof | |
| WO2016032209A2 (ko) | 야누스인산화효소 억제제로서의 치환된 n-(피롤리딘-3-일)-7h-피롤로[2,3-d]피리미딘-4-아민 | |
| WO2017119700A1 (ko) | 융합 페닐 환이 포함된 c-글루코시드 유도체 또는 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 포함하는 약학적 조성물 | |
| WO2012134188A2 (ko) | 신규한 옥사졸리디논 유도체 및 이를 함유하는 의약 조성물 | |
| WO2021101003A1 (ko) | 연속반응 공정에서의 메탄술포닐화 중간체를 이용한 글리플로진 합성 방법 | |
| WO2020036382A1 (ko) | Sglt 저해제의 합성에 유용한 중간체의 제조 | |
| WO2018004202A1 (ko) | 다이페닐메탄 유도체의 제조방법 | |
| WO2021194228A1 (ko) | 암의 예방 또는 치료용 약학적 조성물 | |
| WO2018097403A1 (ko) | 항암제와 디오스제닌의 컨쥬게이트, 이의 제조방법 및 이를 포함하는 항암용 조성물 | |
| WO2020101450A1 (ko) | 아질사르탄 유도체 화합물, 이의 중간체, 이의 제조방법 및 이를 포함하는 조성물 | |
| WO2017150903A1 (en) | Sulfamate derivative compounds, processes for preparing them and their uses | |
| WO2024096408A1 (ko) | 아마이드 및 에스터 작용기를 갖는 지질 및 이의 제조방법 | |
| WO2024029877A1 (ko) | A3 아데노신 수용체 작용제로서의 신규한 퓨린 유도체 화합물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150911 Address after: Queensland, Australia Patentee after: Chwast biotech Pte. Ltd. Address before: Queensland, Australia Patentee before: ALCHEMIA LTD. |
|
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20090909 |